Aquestive Under Pressure After Generic Suboxone Patent Decision By: TalkMarkets November 21, 2018 at 15:48 PM EST In afternoon trading, shares of Aquestive have dropped over 23% to $10.11 Read More >> Related Stocks: Aquestive Therapeutics Inc Dr. Reddy's Laboratories Ltd ADR Endo Int'l Plc Mylan